⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockCanadaToronto

HLS.TO

HLS Therapeutics Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

4.33CAD

+0.1800 (+4.34%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on HLS.TO.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxCAD / 4.33
P/E—
Dvd Ind Yld0.0%
P/B2.43
P/S2.4
Curr EV/T12M EBITDA—
Mkt Cap (CAD)0.1B
Curr EV (CAD)—
2)

Per Share Data

EPS T12M-0.26
DPS0.07
Bk Val Per Sh2.48
Rev/Sh1.65
Cash/Sh0.44
Curr Shares Out30.9M
FCF/Sh0.51
3)

Cash Flow Analysis

P/CF7.3
Curr P/FCF7.8
CF/NI-2.1
Dvd P/O-28.0%
Cash Gen/Cash Reqd5.3
Csh Dvd Cov7.6
CFO/Sales32.4%
Eff Interest Rate10.2%
4)

Growth Potential

Dil EPS 1Y Gr0.0%
Cap 1Y Gr-19.3%
BPS 1Y Gr-13.2%
R&D To Sales—
Retention Rate128.0%
Rev 1Y Gr-2.0%
FCF 1Y Gr93.1%
Assets 1Y Gr-14.0%
5)

Profitability

EBITDA0.0B
EBIT-0.0B
Operating Margin-8.0%
Pretax Margin-16.4%
Net Margin-15.2%
ROA-6.2%
ROE-14.1%
ROC-4.3%
Asset Turnover0.41
6)

Structure

Current Ratio1.05
Quick Ratio0.76
Debt/Assets32.0%
Debt/Com Eq74.6%
Net Debt/EBITDA1.57
Tot Debt/Capital42.7%
Gross Margin81.0%
EBIT/Int Exp-0.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.